Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000494510 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Assessment of IL-8, RANTES, MIG, MCP-1, IP-10, and IL-12p70 and Their Association with Anxiety and Quality of Life in Patients with Chronic Kidney Disease or After Kidney Transplantation.
Int J Mol Sci
December 2024
Department of Reconstructive Surgery and Gynecological Oncology, Pomeranian Medical University in Szczecin, Powstańców Wielkopolskich 72, 70-111 Szczecin, Poland.
Anxiety is a subjective feeling of fear in response to stressful or threatening situations. Chronic diseases (such as chronic kidney disease) or the state after kidney transplantation are such situations and they may result in a decreased quality of life. The main aim of this research was to evaluate if the proteins IL-8, RANTES, MIG, MCP-1, IP-10, and IL-12p70 could be indicators of higher levels of anxiety or decreased quality of life in chronically ill women.
View Article and Find Full Text PDFAchievements, priorities and strategies in pediatric nephrology in Europe: need for unifying approaches or acceptance of differences?
Front Pediatr
December 2024
Department of Pediatric Kidney, Liver, Metabolic and Neurological Diseases, Children's Hospital, Hannover Medical School, Hannover, Germany.
Background: There is a lack of information on the current healthcare systems for children with kidney diseases across Europe. The aim of this study was to explore the different national approaches to the organization and delivery of pediatric nephrology services within Europe.
Methods: In 2020, the European society for Paediatric Nephrology (ESPN) conducted a cross-sectional survey to identify the existing pediatric nephrology healthcare systems in 48 European countries covering a population of more than 200 million children.
Nephrotoxicity in locally advanced head and neck cancer: when the end justifies the means to preserve nutritional status during chemoradiation.
Support Care Cancer
December 2024
Department of Otorhinolaryngology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Cisplatin is a nephrotoxic agent able to damage renal function both in acute and chronic phases. Radiotherapy concomitant with cisplatin 100 mg/m given once every 3 weeks is the curative standard of care for locally advanced head and neck cancer. A prospective evaluation of a wide range of biochemical and anthropometrical parameters, handgrip strength, risk of malnutrition, visual analogue scale of appetite, and body composition was performed before, during, and after concomitant chemoradiotherapy in 60 consecutive patients affected by locally advanced head and neck cancer.
View Article and Find Full Text PDFUltrasonography of vascular access in the hands of nephrology and nephrological nursing professionals in advanced chronic kidney disease units: A tool to improve the quality of care.
Nefrologia (Engl Ed)
December 2024
Servicio de Nefrología, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
From Multimorbidity to Network Medicine in Patients with Rheumatic Diseases.
Rheumatol Ther
February 2025
Department of Clinical and Biological Sciences, Centre for Biostatistics, Epidemiology, and Public Health, University of Turin, Turin, Italy.
Article Synopsis
- The shift from a comorbidity-focused approach to a multimorbidity perspective in managing rheumatic diseases emphasizes the presence of multiple diseases, resulting in greater individual and societal impacts, but often leads to fragmented care.
- Network medicine presents a more integrated approach by examining the interactions and connections between different diseases at a biological level, focusing on shared pathways and mechanisms.
- This paradigm shift allows for a holistic understanding of rheumatic diseases, highlighting their interconnectedness through systemic inflammation and immune system dysregulation.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!